Aarey Drugs & Pharmaceuticals Ltd. - Research Center
524412 AAREYDRUGS Group (B) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 24 | Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | |
|---|---|---|---|---|---|
| Sales | 232.06 | 108.79 | 193.60 | 260.51 | 232.17 |
| Operating profit | 4.90 | 3.19 | 3.67 | 4.92 | 6.35 |
| Interest | 2.46 | 2.16 | 1.14 | 1.10 | 1.08 |
| Gross profit | 4.03 | 2.56 | 3.95 | 5.08 | 6.75 |
| EPS (Rs) | 1.01 | 0.59 | 1.23 | 0.86 | 2.29 |
Half yearly
results in details
| Sep ' 24 | Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | |
|---|---|---|---|---|---|
| Other income | 1.60 | 1.53 | 1.41 | 1.26 | 1.49 |
| Stock adjustment | 4.84 | 6.45 | -6.82 | 463.87 | 3.42 |
| Raw material | 217.66 | 96.73 | 194.24 | -218.81 | 218.81 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 0.36 | 0.22 | 0.34 | 4.54 | 0.23 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 4.30 | 2.20 | 2.17 | 5.99 | 3.36 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.96 | 0.83 | 0.82 | 0.91 | 0.90 |
| Taxation | 0.24 | 0.22 | - | 2.00 | 0.50 |
| Net profit / loss | 2.84 | 1.51 | 3.12 | 2.18 | 5.35 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 28.05 | 25.38 | 25.38 | 25.38 | 23.38 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 2.11 | 2.93 | 1.90 | 1.89 | 2.73 |
| GPM (%) | 1.73 | 2.32 | 2.02 | 1.94 | 2.89 |
| NPM (%) | 1.21 | 1.37 | 1.60 | 0.83 | 2.29 |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis